Form 4: Fulgent Genetics' Chief Scientific Officer Reports Stock Transactions
SEC Form 4 Filing
Hanlin Gao, Chief Scientific Officer of Fulgent Genetics, reports the disposal of shares to cover tax obligations arising from vesting restricted stock units.
Summary
- On March 1, 2024, Hanlin Gao, the Chief Scientific Officer of Fulgent Genetics, disposed of 704 shares of common stock at a price of $23.24.
- Additionally, 268 shares were disposed of on the same date at the same price.
- These transactions were to satisfy tax withholding obligations related to the vesting of restricted stock units granted on February 28, 2022.
- Following these transactions, Gao directly owns 928,965 shares of Fulgent Genetics common stock.
Sentiment
Score: 5
Explanation: Neutral sentiment as the document reports routine stock transactions for tax purposes.
Industry Context
This is a routine disclosure related to executive compensation and tax obligations, common among publicly traded companies.
Stakeholder Impact
- The transactions have a minimal impact on shareholders as they are related to executive compensation and tax obligations.
Key Dates
| Date | Description |
|---|---|
| February 28, 2022 | Date of grant of restricted stock units to the reporting person. |
| March 1, 2024 | Date of stock disposal for tax withholding obligations. |
| March 2, 2022 | Original report on Form 4 filed with the U.S. Securities and Exchange Commission. |
| March 5, 2024 | Date of signature for the report. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.